Detailed answers about Z2 BIOPHARMA SOLUTIONS LIMITED, including incorporation, status, business activity, and accounts information.
When was Z2 BIOPHARMA SOLUTIONS LIMITED founded?
Z2 BIOPHARMA SOLUTIONS LIMITED was officially incorporated on 20 August 2026 and is registered under company number 17411863. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is Z2 BIOPHARMA SOLUTIONS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of Z2 BIOPHARMA SOLUTIONS LIMITED?
Z2 BIOPHARMA SOLUTIONS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does Z2 BIOPHARMA SOLUTIONS LIMITED do?
Z2 BIOPHARMA SOLUTIONS LIMITED operates in the following sectors: 70229 - Management consultancy activities other than financial management, 72110 - Research and experimental development on biotechnology, 85590 - Other education n.e.c.. These SIC codes provide insight into the company's business activities and industry focus.
What is Z2 BIOPHARMA SOLUTIONS LIMITED's registered address?
The registered office address of Z2 BIOPHARMA SOLUTIONS LIMITED is Artisans' House, 7 Queensbridge, Northampton, Northamptonshire, United Kingdom, NN4 7BF. This is the official address filed with Companies House for legal and statutory correspondence.
Is Z2 BIOPHARMA SOLUTIONS LIMITED financially stable?
Financial accounts for Z2 BIOPHARMA SOLUTIONS LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.